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Label-free detection of a few number of nosocomial bacteria 
using a nanophotonic interferometric biosensor
Jesús Maldonadoa, M.-Carmen Estevez*a, Adrián Fernández-Gavelaa, Juan José González-Lópezb, 
Ana Belén González-Guerreroa and Laura M. Lechugaa
Nosocomial infections are a major concern at worldwide level. Early and accurate identification of nosocomial pathogens 
is crucial to provide a timely and adequate treatment. A prompt response also prevents the progression of the infection to 
life-threatening conditions, such as septicemia or generalized bloodstream infection. We have implemented two highly 
sensitive methodologies using an ultrasensitive photonic biosensor based on bimodal waveguide interferometer (BiMW) 
for the fast detection of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), two of the 
most prevalent bacteria associated to nosocomial infections. For that, we have developed a biofunctionalization strategy 
based on the use of a PEGylated silane (silane-PEG-COOH) which provides a highly resistant and bacteria-repelling surface, 
which is crucial to specifically detect each bacterium. Two differentiated biosensor assays have been settled: one based on 
a specific direct immunoassay employing polyclonal antibodies for the detection of P. aeruginosa and another one 
employing aptamers for the direct detection of MRSA. The biosensor immunoassay for P. aeruginosa is fast (it only takes 
12 min) and specific, detecting concentrations down to 49 cfu mL-1 (cfu: colony forming unit). The second one relies on the 
use of an aptamer that specifically detects penicillin-binding protein 2a (PBP2a), a protein only expressed in the MRSA 
mutant, providing the photonic biosensor with the ability of identifying the resistant pathogen MRSA and differentiating it 
from methicillin-susceptible S. aureus (MSSA). Direct, label-free, and selective detection of whole MRSA bacteria was 
achieved with a limit of detection around 29 cfu mL-1. Both results can fulfill the clinical requirements of sensitivity for the 
diagnosis of infections, demonstrating the great potential of this interferometric biosensor device as a versatile, sensitive 
and specific tool for bacterial detection and quantification providing a rapid method for the identification of nosocomial 
pathogens at the point-of-care.
Introduction
Nosocomial infections (infections acquired at the hospital or 
primary care centers) and the emergence of antibiotic 
resistant bacteria are major health care issues. Habitually, 1 
out of 25 patients at hospital becomes infected and as many as 
1 in 9 dies as a consequence of the acquired infection.1,2 
Pseudomonas aeruginosa contributes to 11% of all nosocomial 
infections resulting in high mortality and morbidity rates. It is a 
main causative pathogen of surgical and wound infections, 
urinary tract infections (UTI), cystic fibrosis, and bacteremia, 
with kidney, urinary tract, and upper respiratory tract as 
preferred sites of colonization.3-5 Methicillin-resistant 
Staphylococcus aureus (MRSA) is a leading pathogen 
associated with serious hospital diseases.6-9 MRSA is especially 
alarming given its multidrug resistance pattern to β-lactam 
antibiotics. It causes a range of illnesses, from skin and wound 
infections, to pneumonia and bloodstream infections that can 
result in sepsis and death. MRSA has recently been found as 
the main cause of healthcare associated infections (HAI) which 
in 2014 caused 72,444 invasive infections leading to a 13% of 
mortality 10, 11.
Moreover, an early detection of the causative pathogens of 
nosocomial infections is crucial for prescribing an effective 
treatment before the disease progresses.12 A rapid 
identification of the infective pathogen will greatly help in the 
selection of the most adequate antimicrobial treatment, 
limiting broad-spectrum antibiotic therapy, and reducing 
morbidity and mortality. Current methods for bacteria 
detection in the laboratory involve culture incubation, which 
takes 2-4 days to be completed. Molecular techniques based 
Page 2 of 19Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ARTICLE Journal Name
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
on PCR detect different nosocomial pathogens in an effective 
and specific way.13 However, these techniques also require 
long and laborious protocols, which can take several hours, 
and involve trained personnel and specialized equipment. 
Thus, there is a need of new analytical technologies capable of 
performing pathogen identification, detection and 
quantification with high sensitivity, specificity and speed, 
which circumvent the use of any additional labels and that 
require minimal sample volume and processing. 
Several biosensors have been previously employed to detect 
bacteria, such as surface plasmon resonance (SPR), 
demonstrating in some cases adequate limits of detection. 
However, most of these SPR assays do not offer a direct 
detection of the whole microorganism and rather rely on DNA 
bacterial extraction and identification,14 or require the use of 
nanoparticles and enzymes to amplify the sensor signal.15 
Electrochemical,16-19 and impedimetric biosensors20 have been 
also employed  for nosocomial pathogen detection, showing 
good performance and limit of detection (LOD). However, 
these approaches also need to amplify the signal with enzymes 
and/or nanoparticles.
The development of biosensors for whole bacteria detection is 
challenging because bacteria tend to adhere to surfaces. The 
properties of the sensor surface (i.e. charge and 
hydrophobicity) and the presence of many different antigens 
on the bacteria surface can easily lead to non-specific 
interactions with the sensor surface.21 These interactions can 
affect the overall signal (i.e. resulting in false positive or 
altered quantifications) and must therefore be minimized as 
much as possible. Introducing polyethylene glycol (PEG) 
molecules to cover the surface is a good option as their 
chemical structure confers high flexibility, hydrophilicity and 
biocompatibility. The surface modification with PEG to 
generate bacteria-repelling surfaces has attracted increasing 
attention22-25 and grafted PEG coatings have been employed to 
prevent biofouling of bacteria and cells on different sensor 
surfaces. However, coating protocols involved complex 
procedures, such as inert conditions, toxic solvents (e.g. 
benzene and toluene), intense shaking, and involve long-time 
(>24 h).26, 27 Thus, the generation of a biointerface with the 
capability of preventing non-specific adhesion by a 
straightforward method compatible with a direct 
immobilization would be extremely useful in the biosensor 
field.
Based on this, we have combined a highly sensitive optical 
biosensor with a biosurface functionalization for the rapid, 
label-free and specific detection of nosocomial bacteria. We 
have employed a photonic biosensor based on bimodal 
interferometric waveguides (BiMW), whose sensitivity stands 
as one of the highest reported in the literature for label-free 
detection. The working principle of a BiMW biosensor is based 
on the interferometric design using a single straight waveguide 
(see Figure 1). The BiMW sensor has a first waveguide zone 
exhibiting a single-mode behavior, where only the 
fundamental mode is propagating. After some distance, the 
core thickness of the waveguide is increased, acting as a modal 
splitter and supporting two light modes: the fundamental and 
the first order mode. Both modes keep travelling through the 
sensing region of the bimodal device until the output of the 
waveguide. Both modes have different penetration of their 
evanescent fields into the medium and therefore they have 
different sensitivities to any refractive index change at the 
sensor surface.28 Both modes produce an interference pattern 
at the exit of the waveguide, which is related to the changes 
induced by any interaction event happening on the sensor 
surface. This is due to the fact that both modes are differently 
affected through the evanescent fields which induce a phase 
variation (ΔΦ) in the light output. In order to perform the 
experiments, a sensing window is opened along the bimodal 
section of the waveguide by removing the top-cladding, 
allowing the evanescent wave of both modes to be in contact 
with the biomolecules. This sensing configuration provides an 
excellent sensitivity with a resolution (minimum detectable 
change of refractive index) of only 10-8 RIU. 29, 30
The BiMW biosensor device has been successfully employed 
for the rapid detection of Escherichia coli and Bacillus cereus.31 
We have now modified the silanization protocol to improve 
even more the surface-repelling properties of the biosensor 
surface and its usefulness has been demonstrated with the 
capture and detection of two highly prevalent nosocomial 
bacteria in a label-free way. Specifically, we have: (i) employed 
a silanization protocol, which involves the formation of a 
silane-PEG-COOH layer that avoids non-specific bacteria 
adsorptions on the sensor surface; (ii) developed a BiMW-
based immunoassay for P. aeruginosa detection and; (iii) 
developed a detection assay for the specific detection of MRSA 
based on the use of an aptamer which solely recognizes PBP2a 
protein, not present in methicillin-susceptible S. aureus 
(MSSA). 
The capability of the BiMW biosensor allowed the rapid 
detection (<20 min) of whole bacteria at low concentrations 
(8×102 cfu mL-1), reaching LODs between 29-50 cfu mL-1, 
without the need of additional amplification steps or sample 
pretreatment. Our approach exemplifies a promising 
alternative for simple, direct, rapid, and label-free bacteria 
detection, which can further be employed in decentralized 
settings, such as emergency units, where prompt infection 
detection and bacteria identification become crucial. 
Experimental
Chemical and biological reagents
Page 3 of 19 Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
Triethoxysilane polyethylene glycol carboxylic acid (600 Da) 
(Silane-PEG-COOH) was purchased from Nanocs (USA). 
Solvents for the sensor cleaning process: dry toluene, acetone, 
ethanol, hydrochloric acid (HCl, 35-38%), and methanol were 
supplied by Panreac (Spain). 1-ethyl-3(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC), N-hydroxysulfosuccinimide 
(sulfo-NHS), the reagents for buffers preparation 
glutaraldehyde, and MgCl2 (1 mM) were purchased from 
Sigma-Aldrich (Spain). The buffers employed are the following: 
PBS (10 mM phosphates, 2.9 mM KCl, 137 mM NaCl pH 7.4); 
PBST (PBS with 0.005% Tween 20); MES (0.1 M, 0.5 M NaCl, pH 
5.5) and HEPES (10 mM pH 7.4), SU-8 2025 and 
polydimethylsiloxane (PDMS) polymers used for the flow cell 
fabrication were purchased from Microchem (USA) and 
Sylgard® (USA), respectively. 
Polyclonal anti-Pseudomonas antibody was purchased from 
Abcam® (Spain). All bacteria strains were provided by Vall 
d’Hebron Hospital (Barcelona, Spain). The bacteria were 
streaked onto Luria broth (LB) and incubated overnight at 37º 
C. Purification of bacteria was carried out by centrifugation at 
3000 rpm for 15 min at 4º C. Bacteria were then suspended in 
PBST (P. aeruginosa and E. coli) or PBS (MRSA and MSSA). 
Bacteria concentrations were confirmed by a nanophotometer 
from bioNovacientífica, S.L. (Spain). MRSA aptamer with an 
amino modification at the 3’ end (5’-Aptamer-NH2-3’) and 
recombinant S. aereus PBP2a protein were purchased from 
Base Pair technologies (USA). The dry aptamer was suspended 
in PBS buffer at a final concentration of 100 µM. Once the 
aptamer is dissolved in the buffer, it must be heated to 90 °C 
for 2 min and then cooled down to room temperature before 
use.
BiMW sensor and experimental set-up
The BiMW sensors are designed and fabricated at wafer level 
using standard microelectronic technology in Clean Room 
facilities as previously described 32. Each wafer contains 12 
sensing chips, and each chip included an array of 20 bimodal 
waveguide interferometric sensors of 30 mm length with a 
Fig. 1. a) Scheme of the BiMW device. General view of the main components and the sensing principle. Inset image shows a picture of a BiMW chip 
containing 20 sensors. b) Schematic representation of the biofunctionalization strategy: the Si3N4 sensor surface is modified with silane-PEG-COOH, and 
specific bacteria receptors (antibody or aptamers) are covalently immobilized through the COOH group.
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pitch of 250 µm between them. A scheme of the employed 
experimental set-up is shown in the Supporting Information 
(SI) (Figure S1). The experimental set-up includes the following 
modules: laser, optical components, microfluidic delivery 
system, temperature controller, photodetector, and 
electronics and data acquisition. A He-Ne laser (λ=632.8 nm, 
TE polarization) is employed as light source, a 40X microscope 
objective and a beam expander are employed for light in-
coupling and a two-sectional Si photodiode is employed for 
out-coupling detection. The flow delivery system includes a 
syringe pump for the continuous delivery of the buffer and an 
injection valve connected to a loop of 150 μL for injecting the 
samples. The sensor signal (%) obtained for each measurement 
is expressed as ΔΦ considering that a complete interferometric 
oscillation corresponds to 2π rad phase variation. The data 
acquisition and analysis included a computer with a data 
acquisition card, home-made LabVIEW software, and Origin 
8.0 software (Originlab, Northampton, MA). 
For biosensing evaluation in continuous flow, and in order 
to perform the analysis of aqueous samples, it was necessary 
to incorporate a microfluidic cell and a flow delivery system. 
The microfluidic cell was fabricated in PDMS polymer, building 
a microfluidic cell with eight channels with a pitch of 250 μm 
between them. Each microchannel has a length of 18 mm, a 
height of 50 μm and width of 100 μm, which covers the 
sensing window of each sensor. The alignment of the 
microfluidic system over the bimodal waveguide sensor was 
performed using a home-made aligner, which comprises three 
3-axis micromanipulators and a vacuum pump. In order to 
obtain a continuous flow, the microfluidic cell was connected 
to the fluidic system described in the previous section. The 
volume flow rate was modified according to the bioassay 
requirements, oscillating between 5 and 30 μL min-1.
Sensor chips cleaning and chemical activation
The BiMW sensor chips were sonicated in acetone, ethanol, 
milli-Q water and a 1:1 methanol/HCl solution in order to 
remove organic contamination. Then they were rinsed with 
milli-Q water and dried with a N2 stream. An oxidation step to 
reveal enough oxide groups on the sensor surface was carried 
out by placing the sensor chips in an UV/O3 cleaner (BioForce 
Nanosciences, USA) for 1 h, followed by their exposure to a 
10% nitric acid solution at 75° C for 25 min. After rinsing with 
milli-Q water, the sensor chips were incubated with a silane-
PEG-COOH solution (25 mg mL-1 in ethanol/water 95:5 (v/v)) 
for 2 h at 4 ºC. Then the sensor chips were rinsed with ethanol 
and water and dried with a N2 stream. A final curing step was 
performed by introducing the sensor chips into a glass bottle 
and inside a conventional autoclave for 90 min at 120 ºC and 
at a pressure of 1.5 bars.
 Antibody biofunctionalization and assay development
Antibody immobilization was performed in-situ (i.e. by 
mounting the silanized sensor chip with the flow cell, placed it 
in the optical setup and flowing the different solutions). Anti-
Pseudomonas antibodies were immobilized on the sensor 
surface through a covalent binding to the carboxyl groups 
introduced in the sensor surface during the silanization 
process. Carboxyl groups were first activated by flowing a 
solution of 0.2 M EDC/0.05 M sulfo-NHS in MES buffer. Next, a 
solution of the anti-Pseudomonas (50 µg mL-1 in PBS) was 
injected over the freshly activated sensor surface at a flow rate 
of 10 μL min-1. After immobilization, milliQ water was switched 
to PBST as running buffer, which was circulated over the 
sensor surface at a constant flow of 20 μL min-1. Bacterial 
samples (between 8x102 to 1x107 cfu mL-1 in PBST) were 
loaded into a 150 µL loop and flowed over the sensor surface 
with a flow rate of 20 μL min-1. A 100 mM HCl solution 
(injected at 30 μL min-1) was used as regeneration buffer to 
break the bacteria/antibody interaction. Calibration curves 
were obtained for each bacterium after performing triplicate 
measurements of different samples of known concentration. 
The estimated LOD was calculated as the concentration 
corresponding to the minimum measurable signal, set as three 
times the standard deviation (SD) of the baseline of the sensor 
signal.
Aptamer biofunctionalization and assay development.
Aptamer immobilization was carried out using an ex-situ 
protocol (i.e. outside the optical setup following successive 
incubation/washing steps). In this case, the sensor surface was 
activated with a solution of 0.4 M EDC/0.1 M sulfo-NHS in MES 
buffer for 3 h. After rinsing with water, an aptamer solution (2 
μM in PBS containing 1mM MgCl2) was incubated over the 
sensor surface overnight at room temperature. Finally, the 
sensor chip was washed with PBS and water, dried with a N2 
stream and mounted on the experimental setup. PBS buffer 
was set as running buffer for MRSA detection. All the bacteria 
samples (ranging from 8×102 to 1.6×107 cfu mL-1) were loaded 
in a 150 µL loop and flowed over the sensor surface at a flow 
rate of 20 μL min-1. After each measurement, HCl (25 mM 
injected for 60 s at 20 μL min-1) was flowed to dissociate the 
interaction and regenerate the aptamer and reuse the 
aptasensor. 
SEM analysis
The images of bacterial adhesion to the sensor surface were 
examined by a 400L field-emission scanning microscope (FE-
SEM; FEI Magellan) operated at an acceleration voltage of 2 kV 
and with a working distance of 4.5 mm. A Quanta 650F 
Scanning Electron Microscope (Field Emission Inc., USA), 
operated in 2 kV, was used to assess the selectivity of the 
aptamer for the detection of MRSA, confirming the binding of 
whole MRSA on the aptamer-modified sensor surface. All 
bacteria were first suspended in PBST buffer. Si3N4 surfaces 
without and with silane-PEG-COOH, and biofunctionalized with 
the aptamer were placed in a solution of 107 cfu mL-1 of each 
bacterium for 1 h, and then PBST buffer was replaced with a 
fixation buffer (glutaraldehyde 5% in HEPES buffer) and 
incubated for another hour. The Si3N4 surfaces were washed 
with PBST and dried with a nitrogen stream before 
examination by SEM.
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Results and discussion
Analysis of bacterial adhesion onto silicon nitride sensor 
surface  
A key point in the development of a surface refractive index 
based biosensor is to completely avoid unspecific adsorptions. 
In general, any adsorbed mass on the surface produces a 
refractive index change and, therefore, renders in altered 
sensor values that affect an accurate quantification. In this 
context, bacteria are especially complex targets since they are 
prone to adsorb on any type of surfaces, giving rise to 
unspecific responses in biosensors, which cannot be 
distinguishable from the specific ones. The design of a surface 
that minimizes other bacteria adhesion, that only allows the 
interaction of the target bacteria with their specific 
bioreceptor but not with the sensor surface, and that ideally 
avoids additional blocking steps, is mandatory for the 
achievement of competitive and high-performance bacteria 
biosensor. PEG is known to decrease the interaction between 
silicon surfaces and biomolecules because of its steric 
stabilization forces and chain mobility.33 Therefore, we used a 
silane containing a short chain of PEG (MW=600 Da) with a 
carboxylic group at the other end, in such a way that it 
provided a reactive group to be further coupled to 
bioreceptors. A simple silanization protocol was performed, 
which involved the incubation of the oxidized Si3N4 surface 
with the silane to form an assembled layer, followed by a high-
pressure and high-temperature curing step (achieved by 
means of an autoclave) to stabilize the bonds. Employing this 
strategy, a stable and dense PEGylated layer was obtained as 
assessed by X-ray photoelectron spectroscopy (XPS) (see SI for 
detailed information). The non-specific adsorptions of 
different bacteria on Si3N4 surfaces coated with the silane-
PEG-COOH were first evaluated using S. aureus, as a 
representative model of Gram-positive bacteria and E. coli and 
P. aeruginosa as representative of Gram-negative bacteria. 
They were selected since they are three of the most common 
pathogens identified in nosocomial infections. As can be seen 
in Figure 2 (top), significant non-specific adsorptions of 
bacteria over untreated Si3N4 surfaces were clearly observed, 
being particularly high for S. aureus (Gram-positive) in 
comparison with E. coli and mainly with P. aeruginosa (Gram-
negative), which showed a much lower adhesion. These results 
exemplify also how different bacteria can behave in terms of 
adsorption depending on their own surface properties. Even in 
the case of P. aeruginosa, with an apparently low adhesion, 
the resultant signal in the biosensor could be comparatively 
high, considering the size of bacteria and the extremely 
sensitivity level of our device.30 On the other hand, the SEM 
images of the silanized surfaces demonstrates that the surface 
treatment with PEGylated compounds such as the silane-PEG-
COOH helps prevent the bacterial adhesion (see Fig. 2, 
bottom) with all the three bacteria tested. Finally, the ability of 
the silane-PEG-COOH modified surface to attach biomolecules 
was then assessed with the immobilization of the antibodies 
(through the free Lys in their structure) and confirmed using 
XPS. For this experiment, silicon nitride surface was cleaned 
and modified with silane-PEG-COOH following the same 
procedure described. Then the carboxyl groups were activated 
with a solution of EDC/sulfo-NHS and an antibody solution (50 
µg mL-1) was incubated over silicon nitride surface during 30 
min at room temperature. The details of XPS experiments and 
the comparison of the survey spectra for untreated Si3N4, 
Fig. 2. SEM images of the bacterial adhesion in untreated Si3N4 sensor surfaces (top) and in sensor surface treated with PEG-silane-COOH (bottom). Scale bars 
of inset images (top) are 2, 5, and 1 µm, respectively.
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silane-PEG-COOH and sensor surfaces with immobilized 
antibody are discussed in SI and Figure S1-S4 therein. 
Immunoassay for the detection of Pseudomonas aeruginosa
The BiMW sensor modified with silane-PEG-COOH was placed 
in the experimental set-up. Then, the carboxyl groups of the 
silane-PEG-COOH surface were activated with a solution of 
EDC/sulfo-NHS. An antibody solution was flowed over the 
sensor surface and the immobilization was monitored in real-
time. The mean immobilization signal of the antibody was 
7.5±2 x2π rad, which represents a high and reproducible 
antibody coverage due to the covalent attachment (Figure S5). 
Suspensions of P. aeruginosa at different concentrations were 
sequentially flowed through the sensor surface. 
Representative signals of specific P. aeruginosa detection (1.6 
x 105 cfu mL-1) and non-specific E. coli (1 x 105 cfu mL-1) used as 
control are shown in Fig.3a. These results show a ΔΦ of 0.4x2π 
rad for the detection of P. aeruginosa and a negligible signal 
for the E. coli sample, respectively, which confirms the 
specificity of the immunoassay provided by the antibody. 
Additional E. coli samples at different concentrations (from 105 
to 107 cfu mL-1) were also flowed and no signal was observed 
for any of them, confirming that the signal contribution was 
coming only from the specific detection of P. aeruginosa (see 
Figure 3b). The interaction between the antibodies and the 
captured bacteria can be further interrupted by the injection 
of 100 mM HCl for 1 min (see sensorgram in Fig.3c as a 
representative binding and regeneration cycle) without 
altering the sensor surface density of antibodies, as can be 
seen by the complete recovery of the baseline. Under these 
conditions, the biosensor was reusable up to 5 cycles using the 
same bioreceptor layer before degradation of the antibody 
layer (i.e. the signal corresponding to bacteria binding 
decreased significantly). A calibration curve was generated 
after analyzing a wide range of bacteria concentrations. The 
lowest concentration analyzed was 8x102 cfu mL-1 resulting in 
a ΔΦ of 0.074x2π rad. (see Fig. 3b). Considering the sample 
volume injected (i.e. 150 µL) this corresponds to 120 bacteria 
detected. Moreover, considering the minimum measurable 
signal, which was set as three times the standard deviation of 
the baseline (8.5×10-5×2π rad), an estimated LOD of 49 cfu mL-
1 was achieved (i.e. around 8 bacteria in a 150 µL volume 
sample). These concentration values fall comfortably within 
the cut-off values in infections such as UTIs (i.e. between 104-
105 cfu mL-1)34 upper and low respiratory tract infections (cut-
off at 103 cfu mL-1)35, 36 and could even be suitable for more 
restrictive cut-offs such as for blood stream infections.37
Aptamer-based assay for the detection of MRSA
Detection of PBP2a protein
Methicillin-resistant S. aureus emerges after acquiring the 
mecA resistance gene, which encodes PBP2a protein.38, 39 This 
protein is a unique transpetidase that catalyzes cell-wall 
crosslinking and it is not inhibited by β-lactam antibiotics 
(contrary to what happens with the four S. aureus native 
Penicillin-binding proteins (PBPs)). Therefore, the detection of 
this distinctive protein, only present in the MRSA strain, is a 
specific approach to identify these bacteria. Besides antibodies 
commercially available, a specific aptamer was recently 
developed that specifically recognizes PBP2b. In order to take 
advantage of the silane-PEG-COOH chemistry, we decided to 
modify the aptamer with an amino (-NH2) terminal group and 
use the same surface chemistry employed with the antibody 
previously. We first attempted the detection of pure PBP2a 
protein in order to evaluate the affinity and the integrity of the 
aptamer after immobilization and its specificity against other 
interfering proteins. As negative control, we selected a protein 
located in the cell wall of the Mycobacterium tuberculosis (also 
Fig. 3. (a) Real time sensorgrams obtained for P. aeruginosa and E. coli 
(negative control). (b) Calibration curve for P. aeruginosa (black squares) 
and for non-specific bacteria E. coli (red circles). Inset graph: linear 
representation with exponential fitting (y= y0 + A ) of the P.  𝑒 ―𝑥/1
aeruginosa detection. Linear part was fitted to a linear regression 
(y=1.7484 × 10-6x, R2=0.9846). All data show mean + SD of triplicate 
measurements. (c) Real time sensorgram of P. aeruginosa detection (1.6 x 
103 cfu mL-1), followed by a regeneration step (dash line indicates the 
baseline).
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a gram-positive bacterium, such as MRSA) as PBP2b in MRSA. 
The capability of the aptamer to detect PBP2a protein was 
evaluated at different concentrations (between 50 and 500 ng 
mL-1); the negative control protein was tested at two 
concentrations: 500 ng mL-1 and 5 μg mL-1 (ten times higher 
than the highest concentration of PBP2b evaluated). 
Representative signals of two concentrations of PBP2a and the 
negative control are shown in Fig. 4a. These signals show a ΔΦ 
of 0.1×2π rad for the detection of 100 ng mL-1, and 0.3×2π rad 
for the detection of 500 ng mL-1 of PBP2a protein, respectively, 
while the signals for the negative controls are negligible, 
indicating the excellent specificity of the aptamer. The range of 
PBP2a concentrations evaluated showed a linear 
concentration-dependent profile as can be seen in Figure 4b,c. 
A calibration curve for the direct detection of PBP2a was 
generated, reaching an estimated LOD of 3.27 ng mL-1 (Fig. 4c).
Detection of MRSA bacteria
In order to evaluate the capability of the aptasensor for whole 
MRSA detection and establish its overall performance, several 
solutions of MRSA bacteria were prepared in PBS and injected 
over the aptamer modified sensor surface. MSSA was also 
analyzed to assess the specificity provided by the aptamer. 
Representative signals of MRSA detection (1.6×106 cfu mL-1) 
and MSSA (2×106 cfu mL-1) are shown in Fig. 4a. These signals 
show a ΔΦ of 0.41×2π rad for the detection of MRSA, and no 
signal for the MSSA sample. We established the regeneration 
conditions that enable the dissociation of the MRSA-aptamer 
binding, without affecting the aptamer activity or integrity as 
can be seen in Fig. 4b, the use of 25 mM HCl for 60 s was 
enough to disrupt the interaction and remove all the bacteria 
bound to the aptamer, therefore, fully recovering the baseline. 
Other solutions such as NaOH or NaCl were not able to 
dissociate the interaction or they affected the conformation of 
the aptamer, disabling it for further interactions. Under the 
optimal regeneration conditions, the biosensor could be 
reused up to 12 cycles before signal decrease (see figure S6 in 
SI). Figure 4c shows some representative signals of specific 
MRSA detection at different concentrations. The calibration 
curve is depicted in Figure 4d. A ΔΦ signal of 0.04×2π rad was 
observed for the lowest concentration injected (8×102 cfu mL-
1) and increased gradually as the bacteria concentration was 
also higher. Considering the baseline signal (8.5×10-5×2π rad), 
an estimated LOD around 29 cfu mL-1 was calculated from the 
linear fitting for the MRSA detection (inset in the Fig. 4d). This 
level is comparable to the one obtained for P. aeruginosa using 
antibodies, complying also with the current clinical 
requirements for the detection of nosocomial infections. 40, 41
Fig. 3. a) Real time sensorgrams obtained for the detection of PBP2a protein 
and for the control protein over the aptamer biofunctionalized sensor. b) 
Real-time sensorgrams for several PBP2a concentrations over aptamer-
modified sensor chips. c) Calibration curve obtained for PBP2a protein in 
buffer. All data show mean + SD of triplicate measurements.
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Fig. 4. a) Real time sensorgrams of MRSA (black line) versus MSSA measurement (Red line); b) Real time sensorgram of the MRSA detection, followed by the 
regeneration step with HCl 25 mM; c) Real time sensorgrams showing the detection of MRSA bacteria at different bacteria concentrations (red dashed line 
indicates the baseline). d) Calibration curve for whole MRSA detection with the BiMW aptasensor. Signal obtained for MSSA at 106 cfu mL-1 is also shown. Inset 
graph shows the linear fitting (y=2.967×10-6x, R2=0.9697) for the low bacteria concentration range (i.e. between 800 and 1.6 ×105 cfu mL-1). All data show mean + 
SD of triplicate measurements
Fig. 5. SEM study for the confirmation of the selectivity and specificity of the MRSA aptamer biofunctionalized Si3N4 sensor surfaces. a) MSSA (107 cfu mL-1) on a 
Si3N4 sensor surface modified with only silane-PEG-COOH (i.e. no aptamer immobilized); b) MRSA (107 cfu mL-1) on a Si3N4 sensor surface modified with only 
silane-PEG-COOH (i.e. no aptamer immobilized); c) MSSA (107 cfu mL-1) on a sensor surface with MRSA aptamer immobilized and d) MRSA (107 cfu mL-1) on a 
sensor surface with MRSA aptamer immobilized.
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Conclusions
We have implemented a rapid, label-free, and highly sensitive 
BiMW biosensor able to identify and quantify nosocomial 
bacteria. Our strategy is based on the combination of a sensor 
surface modified with a silane-PEG-COOH, which provides an 
excellent bacteria-repelling coating, and the use of appropriate 
specific receptors (i.e. both antibodies and aptamers). With 
this biofunctionalization strategy, non-specific bacteria 
adsorption was successfully eliminated, avoiding extra blocking 
steps, which can lengthen the process and affect the final 
sensitivity. The silane-PEG-COOH surface was evaluated using 
SEM to assess its performance and its bacteria-repelling 
capabilities and the biofunctionalized surface was additionally 
characterized with XPS. The subsequent addition of a suitable 
antibody layer led to a BiMW immunosensor that showed a 
selective label-free detection of P. aeruginosa with a valuable 
LOD of only 49 cfu mL-1. Moreover, the versatile chemistry 
provided by the COOH groups in the silanized sensor chips, 
facilitated also the immobilization of an amino-modified 
aptamer, providing an efficient and highly specific detection of 
MRSA bacteria, reaching a LOD of 29 cfu mL-1, avoiding any 
recognition of the MSSA. The combination of the high 
sensitivity of the BiMW sensor with the features of the specific 
aptamer represents an excellent analytical tool to distinguish 
between resistant and susceptible S. aureus in a direct and 
rapid way.
The methodology used to generate the bacteria-repelling 
surface, based on a simple process of autoclaving curing of the 
reactive silane, can be further employed as a general 
methodology for developing stable modified sensor surfaces 
for other silicon photonic biosensors. Overall, the results 
obtained demonstrate the competitive potential of the BiMW 
biosensor technology, in combination with a silane-PEG-COOH 
interface, to provide a label-free, rapid, stable, selective and 
specific biosensor device for the identification of nosocomial 
pathogens. Moreover, our approach could be further 
translated to a multiplexed configuration, by simply addressing 
the immobilization of different antibodies and aptamers in 
each individual bimodal waveguides and could be easily 
integrated in a point-of-care instrument to be deployed in 
clinical settings, in order to facilitate fast bacterial diagnosis, 
one of the urgent needs in our healthcare system.
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 1. XPS analysis 
The XPS experiments were performed using a Phoibos 150 analyzer (SPECS GmbH, Berlin, 
Germany) in ultra-high vacuum condition (base pressure 1 × 10-10 mbar). A monochromatic 
AlKα X-ray source (1486.74 eV) operating at 400 W was employed. Survey spectra were 
collected from 0 to 1380 eV with a pass energy of 50 eV, and high-resolution spectra were 
collected for each element (e.g. C, N and O) with a pass energy of 20 eV. Survey and high-
resolution spectra were collected at 0º take off angle, defined as the angle spanned by the 
electron path to the analyser and the sample surface. The spectra were obtained at room 
temperature. 
XPS survey spectra illustrated significant changes in carbon, silicon, oxygen and nitrogen 
peaks, due to the addition of the different molecular layers (see Figure S2).1 The spectra 
with the antibody immobilized shows a significant increase of the carbon and decrease of the 
nitrogen and the silicon, both being contributions from the Si3N4 substrate and the SiO2 
oxidation layer. This demonstrates how Si3N4 is not exposed but coated with silane-PEG-
COOH and antibodies. The elemental analysis indicates a remarkable increase of carbon 
content after antibody immobilization. Carbon increased from 6.2% (Si3N4) to 20.7% on the 
antibody coated surface while nitrogen levels decreased on the silanized surface and was 
even lower with the antibody attached (see Table S1). The high-resolution C 1s spectra (see 
Figure S3) showed that the C 1s photoelectron peaks are much broader after the 
immobilization with antibodies. The C 1s peaks were deconvoluted according to binding 
energies of carbons in antibody. The first peak was centred at 284.7 (Figure S3a) and 
related to aliphatic carbon (C-C). The second peak at 286.5 eV corresponds to carbon 
bonded to oxygen group (C-O) (Figure S3b) which evidences the PEG-silane-COOH 
presence. The antibody attachment by the peak around 287.5 eV, corresponds to –C (-O)-
NH2 peptide carbon (Figure S3c).2, 3 The binding energies of N 1s detected on the samples 
(close to 400 eV) are typical for organic materials and are related to C-N bonds, 4, 5 at 398.2 
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eV, the spectre corresponding to Si3N4 (see Figure S4a). At the same time, the silane-PEG-
COOH (Figure S4.b) and the antibody onto Si3N4  (Figure S4c) are indicative of complete 
coverage of the silicon nitride surface. The component around 402 eV peak was assigned to 
imide-N, found on the amino acid proteins (see Figure S4.c). 6 
 
 
Figure S1. Schematic representation of the experimental set-up for the evaluation of the BiMW 
biosensors system. The set-up comprised three mainly components: a flow cell and flow delivery 
system, optical system for in coupling of the light and the read-out and data acquisition system. 
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 Figure S2. XPS survey spectra of: a) Si3N4, b) Si3N4 coated with silane-PEG-COOH and c) silanized 
surface with antibody covalently attached to the COOH groups. 
 
Figure S3. XPS high resolution spectra of C 1s, a) untreated Si3N4, b) silane-PEG-COOH and c) 
antibody immobilized. 
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 Figure S4. XPS high resolution spectra of N 1s, a) untreated Si3N4, b) silane-PEG-COOH and c) 
antibody immobilized. 
 
 
Figure S5. Real-time sensorgram showing the antibody immobilization. Phase variation due to the 
refractive index bulk change and the immobilization of antibody is 7.7×2π rad (ΔΦIn-ΔΦOut). 
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 Figure S6. Real-time detection of 1, 7, 8, 10, and 12 measurement-regeneration cycles of MRSA 
detection regenerated with 25 mM HCl. 
 
Table S1. Elemental composition of Si3N4 susbtrates before and after surface modification with 
silane-PEG-COOH and antibody 
Sample Elemental composition (at %) 
C N O Si 
SI3N4 6.26 33.62 14.59 45.53 
Silane-PEG 10.15 26.68 21.86 41.31 
Antibody 23.32 22.37 20.7 33 
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